Vivani Medical (VANI) Total Current Liabilities (2014 - 2026)
Vivani Medical (VANI) posted quarterly Total Current Liabilities of $6.8 million for Q1 2026, up 9.29% year-over-year from $6.2 million in Q1 2025, and up 2.62% quarter-over-quarter from $6.6 million in Q4 2025.
Vivani Medical (VANI) Total Current Liabilities (2014 - 2026) Analysis & Trends
Vivani Medical's Total Current Liabilities history runs 13 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 9.29% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 9.29% YoY), while the FY2025 annual figure was $6.6 million, up 10.29% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $6.8 million, up from $6.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $7.4 million in Q3 2023, with the low at $2.4 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $6.2 million (2025), against an average of $5.9 million.
- Peak annual rise in Total Current Liabilities reached 227.04% in 2022, while the deepest fall reached 65.63% in 2022.
- Vivani Medical's Total Current Liabilities stood at $6.8 million in 2022, then dropped by 16.11% to $5.7 million in 2023, then advanced by 4.6% to $6.0 million in 2024, then increased by 10.29% to $6.6 million in 2025, then increased by 2.62% to $6.8 million in 2026.
- Business Quant data shows VANI's Total Current Liabilities at $6.8 million in Q1 2026, $6.6 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 6.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.66 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 5.99 Mn |
| Sep 30, 2024 | 6.27 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Mar 31, 2024 | 6.14 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Sep 30, 2023 | 7.43 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 5.86 Mn |
| Dec 31, 2022 | 6.82 Mn |
| Sep 30, 2022 | 5.62 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | 3.92 Mn |